Literature DB >> 26884346

Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.

Mari Dezawa1.   

Abstract

While mesenchymal stem cells (MSCs) are easily accessible from mesenchymal tissues, such as bone marrow and adipose tissue, they are heterogeneous, and their entire composition is not fully identified. MSCs are not only able to differentiate into osteocytes, chondrocytes, and adipocytes, which belong to the same mesodermal lineage, but they are also able to cross boundaries between mesodermal, ectodermal, and endodermal lineages, and differentiate into neuronal- and hepatocyte-like cells. However, the ratio of such differentiation is not very high, suggesting that only a subpopulation of the MSCs participates in this cross-lineage differentiation phenomenon. We have identified unique cells that we named multilineage-differentiating stress-enduring (Muse) cells that may explain the pluripotent-like properties of MSCs. Muse cells comprise a small percentage of MSCs, are able to generate cells representative of all three germ layers from a single cell, and are nontumorigenic and self-renewable. Importantly, cells other than Muse cells in MSCs do not have these pluripotent-like properties. Muse cells are particularly unique compared with other stem cells in that they efficiently migrate and integrate into damaged tissue when supplied into the bloodstream, and spontaneously differentiate into cells compatible with the homing tissue. Such a repairing action of Muse cells via intravenous injection is recognized in various tissues including the brain, liver, and skin. Therefore, unlike ESCs/iPSCs, Muse cells render induction into the target cell type prior to transplantation unnecessary. They can repair tissues in two simple steps: collection from mesenchymal tissues, such as the bone marrow, and intravenous injection. The impressive regenerative performance of these cells provides a simple, feasible strategy for treating a variety of diseases. This review details the unique characteristics of Muse cells and describes their future application for regenerative medicine.

Entities:  

Mesh:

Year:  2016        PMID: 26884346     DOI: 10.3727/096368916X690881

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  36 in total

Review 1.  Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.

Authors:  Ania Dabrowski; Thomas J Robinson; Ryan J Felling
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-02       Impact factor: 5.081

2.  The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation.

Authors:  Nicola Alessio; Servet Özcan; Kazuki Tatsumi; Ayşegül Murat; Gianfranco Peluso; Mari Dezawa; Umberto Galderisi
Journal:  Cell Cycle       Date:  2016-07-27       Impact factor: 4.534

Review 3.  Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review.

Authors:  Zahra Fazeli; Atieh Abedindo; Mir Davood Omrani; Sayyed Mohammad Hossein Ghaderian
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

Review 4.  Pluripotent Stem Cells in Adult Tissues: Struggling To Be Acknowledged Over Two Decades.

Authors:  Deepa Bhartiya
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

Review 5.  New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.

Authors:  Marcin Wysoczynski; Abdur Khan; Roberto Bolli
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

Review 6.  DNA repair fidelity in stem cell maintenance, health, and disease.

Authors:  Chinnadurai Mani; P Hemachandra Reddy; Komaraiah Palle
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-04-04       Impact factor: 5.187

7.  Very small embryonic-like stem cells (VSELs) regenerate whereas mesenchymal stromal cells (MSCs) rejuvenate diseased reproductive tissues.

Authors:  Deepa Bhartiya; Pushpa Singh; Diksha Sharma; Ankita Kaushik
Journal:  Stem Cell Rev Rep       Date:  2021-08-19       Impact factor: 6.692

8.  The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.

Authors:  Masahiro Iseki; Masamichi Mizuma; Shohei Wakao; Yoshihiro Kushida; Katsuyoshi Kudo; Masahiko Fukase; Masaharu Ishida; Tomoyuki Ono; Mitsuhiro Shimura; Ichiro Ise; Yukie Suzuki; Teruko Sueta; Ryuta Asada; Shinobu Shimizu; Yoshiyuki Ueno; Mari Dezawa; Michiaki Unno
Journal:  Surg Today       Date:  2020-09-11       Impact factor: 2.549

9.  Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.

Authors:  Nao Uchida; Yoshihiro Kushida; Masaaki Kitada; Shohei Wakao; Naonori Kumagai; Yasumasa Kuroda; Yoshiaki Kondo; Yukari Hirohara; Shigeo Kure; Gregorio Chazenbalk; Mari Dezawa
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

10.  Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy.

Authors:  Toshihiko Suzuki; Yoshiaki Sato; Yoshihiro Kushida; Masahiro Tsuji; Shohei Wakao; Kazuto Ueda; Kenji Imai; Yukako Iitani; Shinobu Shimizu; Hideki Hida; Takashi Temma; Shigeyoshi Saito; Hidehiro Iida; Masaaki Mizuno; Yoshiyuki Takahashi; Mari Dezawa; Cesar V Borlongan; Masahiro Hayakawa
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-22       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.